Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study

BACKGROUND: In neuroblastoma (NB), the most powerful prognostic marker, the MYCN amplification (MNA), occasionally shows intratumoural heterogeneity (ITH), i.e. coexistence of MYCN-amplified and non-MYCN-amplified tumour cell clones, called heterogeneous MNA (hetMNA). Prognostication and therapy all...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Berbegall, Ana P., Bogen, Dominik, Pötschger, Ulrike, Beiske, Klaus, Bown, Nick, Combaret, Valérie, Defferrari, Raffaella, Jeison, Marta, Mazzocco, Katia, Varesio, Luigi, Vicha, Ales, Ash, Shifra, Castel, Victoria, Coze, Carole, Ladenstein, Ruth, Owens, Cormac, Papadakis, Vassilios, Ruud, Ellen, Amann, Gabriele, Sementa, Angela R., Navarro, Samuel, Ambros, Peter F., Noguera, Rosa, Ambros, Inge M.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988829/
https://ncbi.nlm.nih.gov/pubmed/29755120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0098-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki